This course is a one hour video-based education opportunity to educate physicians on how to identify individuals at risk for more common and rarer hereditary cancer syndromes, how patients should be managed as there have been recent changes to National Comprehensive Cancer Network (NCCN) guidelines for many specific genes, and the impact of a genetic patient navigator on high-risk patient care. the practice standard used will be NCCN guidelines, but as guidelines are changing rapidly, this event would provide a succinct review to keep learners abreast of new information. A hereditary cancer predisposition affects 10% of the population, and so early identification and patient follow-through on management is necessary to prevent cancer in these individuals and their families. Physician knowledge and competency will be evaluated with a pre- and post-test assessment. 

Method of Participation

This continuing medical education enduring material is in a video format. References are linked to online resources.

To receive a maximum of 0.75 AMA PRA Category 1 Credit(s)™ you should:

• View the video in this enduring material.
• Complete the posttest (A passing score of 80% is required).
• Complete and submit the CME evaluation form.
• The estimated time to complete this activity, including review of the materials, is 0.75 hour(s).

Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.

If you have questions about the participation process, please e-mail the UT Southwestern Medical Center, cmeregistrations@utsouthwestern.edu.